These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30971219)

  • 1. The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.
    Babic A; Pijuk A; Brázdilová L; Georgieva Y; Raposo Pereira MA; Poklepovic Pericic T; Puljak L
    BMC Med Res Methodol; 2019 Apr; 19(1):77. PubMed ID: 30971219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
    Barcot O; Boric M; Poklepovic Pericic T; Cavar M; Dosenovic S; Vuka I; Puljak L
    BMC Med Res Methodol; 2019 Aug; 19(1):170. PubMed ID: 31382898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessments of attrition bias in Cochrane systematic reviews are highly inconsistent and thus hindering trial comparability.
    Babic A; Tokalic R; Amílcar Silva Cunha J; Novak I; Suto J; Vidak M; Miosic I; Vuka I; Poklepovic Pericic T; Puljak L
    BMC Med Res Methodol; 2019 Apr; 19(1):76. PubMed ID: 30953448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.
    Saric F; Barcot O; Puljak L
    J Clin Epidemiol; 2019 Aug; 112():53-58. PubMed ID: 31009658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.
    Barcot O; Boric M; Dosenovic S; Cavar M; Jelicic Kadic A; Poklepovic Pericic T; Vukicevic I; Vuka I; Puljak L
    BMC Med Res Methodol; 2020 Sep; 20(1):240. PubMed ID: 32993499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.
    Puljak L; Ramic I; Arriola Naharro C; Brezova J; Lin YC; Surdila AA; Tomajkova E; Farias Medeiros I; Nikolovska M; Poklepovic Pericic T; Barcot O; Suarez Salvado M
    J Clin Epidemiol; 2020 Jul; 123():114-119. PubMed ID: 32247026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of use and adequacy of Cochrane risk of bias tool 2 in non-Cochrane systematic reviews published in 2020: Meta-research study.
    Babić A; Barcot O; Visković T; Šarić F; Kirkovski A; Barun I; Križanac Z; Ananda RA; Fuentes Barreiro YV; Malih N; Dimcea DA; Ordulj J; Weerasekara I; Spezia M; Žuljević MF; Šuto J; Tancredi L; Pijuk A; Sammali S; Iascone V; von Groote T; Poklepović Peričić T; Puljak L
    Res Synth Methods; 2024 May; 15(3):430-440. PubMed ID: 38262609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Cochrane reviews, risk of bias assessments for allocation concealment were frequently not in line with Cochrane's Handbook guidance.
    Propadalo I; Tranfic M; Vuka I; Barcot O; Pericic TP; Puljak L
    J Clin Epidemiol; 2019 Feb; 106():10-17. PubMed ID: 30312657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of risk of bias assessments in a sample of intervention systematic reviews, Part II: focus on risk of bias tools reveals few meet current appraisal standards.
    Kolaski K; Clarke M; Logan LR
    J Clin Epidemiol; 2024 Oct; 174():111460. PubMed ID: 39025376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of bias assessments for blinding of participants and personnel in Cochrane reviews were frequently inadequate.
    Barcot O; Boric M; Dosenovic S; Poklepovic Pericic T; Cavar M; Puljak L
    J Clin Epidemiol; 2019 Sep; 113():104-113. PubMed ID: 31132470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-review agreement of risk-of-bias judgments varied in Cochrane reviews.
    Könsgen N; Barcot O; Heß S; Puljak L; Goossen K; Rombey T; Pieper D
    J Clin Epidemiol; 2020 Apr; 120():25-32. PubMed ID: 31866473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of bias assessment of sequence generation: a study of 100 systematic reviews of trials.
    Wuytack F; Regan M; Biesty L; Meskell P; Lutomski JE; O'Donnell M; Treweek S; Devane D
    Syst Rev; 2019 Jan; 8(1):13. PubMed ID: 30621793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews.
    Rademaker MM; Ramakers GGJ; Smit AL; Hooft L; Stegeman I
    PLoS One; 2020; 15(7):e0235535. PubMed ID: 32650340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews.
    Kabir A; Sofi-Mahmudi A; Karimi Behnagh A; Eidkhani V; Baradaran HR; Kabiri P; Haghdoost A; Mesgarpour B
    Arch Iran Med; 2022 Jun; 25(6):375-382. PubMed ID: 35943017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.
    Barcot O; Boric M; Dosenovic S; Puljak L
    BMC Med Res Methodol; 2021 Jul; 21(1):149. PubMed ID: 34275437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of bias tools in systematic reviews of health interventions: an analysis of PROSPERO-registered protocols.
    Farrah K; Young K; Tunis MC; Zhao L
    Syst Rev; 2019 Nov; 8(1):280. PubMed ID: 31730014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review.
    Jordan VM; Lensen SF; Farquhar CM
    J Clin Epidemiol; 2017 Jan; 81():72-76. PubMed ID: 27622779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of bias over time in updates of Cochrane oral health reviews.
    Faggion CM; Aranda L; Pandis N; Alarcón MA; Diaz KT
    J Dent; 2019 Jan; 80():63-68. PubMed ID: 30342067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced access to recommendations from the Cochrane Handbook for improving authors' judgments about risk of bias: A randomized controlled trial.
    Barcot O; Ivanda M; Buljan I; Pieper D; Puljak L
    Res Synth Methods; 2021 Sep; 12(5):618-629. PubMed ID: 34050603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High and unclear risk of bias assessments are predominant in diagnostic accuracy studies included in Cochrane reviews.
    Di Girolamo N; Winter A; Meursinge Reynders R
    J Clin Epidemiol; 2018 Sep; 101():73-78. PubMed ID: 29777798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.